Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments
Xconomy
MARCH 15, 2019
A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA. The company, which CEO Bob Manning says has raised about $2.5
Let's personalize your content